Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
ABCC6 Gene Sequencing for Generalized Arterial Calcification Type 2 (Infantile) โ Genetic Test in UAE
Executive Summary & Core Metrics
Comprehensive ABCC6 gene sequencing via Next-Generation Sequencing (NGS) with diagnostic sensitivity of 99.9%. Premium home collection service available daily 8 AM โ 11 PM with ISO-certified cold-chain transport. DHA-licensed genetic counselling provided post-report. Insurance direct billing verification via WhatsApp +971 54 548 8731.
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM โ 11 PM)
Clinical Guidance
Telephonic Post-Test Clinical Interpretation by DHA-Licensed Consultant Medical Geneticist
Insurance
Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The ABCC6 Gene Arterial Calcification Type 2 (Generalized, Infantile) Genetic Test is a definitive molecular diagnostic that screens the entire coding region of the ABCC6 gene for pathogenic variants, the primary cause of Generalized Arterial Calcification of Infancy (GACI) type 2 โ a life-threatening autosomal recessive disorder characterized by extensive calcification of the internal elastic lamina of medium and large arteries.
| Feature | Our Test (NGS Sequencing) | Closest Alternative (Targeted Panel) |
|---|---|---|
| Precision | Full gene sequencing with copy number variant detection | Limited to predefined hot-spot mutations |
| Methodology | Next-Generation Sequencing (NGS) with Sanger confirmation | PCR-based fragment analysis or Sanger sequencing of select exons |
| Turnaround Time | 3โ4 Weeks (ISO cold-chain preserved) | 4โ6 Weeks |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Geneticist, I emphasize that this NGS test provides a molecular confirmation crucial for differential diagnosis of GACI, but results must be interpreted alongside clinical presentation, echocardiographic findings, and biochemical markers. False reassurance from a negative result is possible if the variant is deep intronic or a novel missense; thus, lifelong multidisciplinary follow-up remains essential.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
โ ๏ธ Medication Warning
Do not discontinue prescribed medication (e.g., bisphosphonates, etidronate, or antihypertensives) without consulting your treating physician. Genetic results guide long-term management but do not replace acute care interventions.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active febrile illness, recent blood transfusion (<2 weeks), or anticoagulation that cannot be safely paused per physician.
- Immediate ER Visit if: New onset of respiratory distress, cyanosis, sudden hypertension crisis, or seizure within 48 hours of blood draw.
- Post-test Safety: Minor bruising at venipuncture site is common; however, signs of limb ischemia or expanding hematoma demand urgent care.
Patient FAQ & Clinical Guidance
1. What is the ABCC6 gene test, and why is it ordered for my infant?
This test reads the entire ABCC6 gene to identify disease-causing mutations responsible for severe arterial calcification in newborns, enabling targeted therapy and family planning.
2. How is the sample collected, and does insurance cover it in the UAE?
A certified mobile phlebotomist collects a blood sample at your home between 8 AM and 11 PM, and we verify direct billing with your insurer via WhatsApp at +971 54 548 8731.
3. What happens after I receive a positive mutation result?
You will receive immediate telephonic genetic counselling and a personalized clinical correlation report, followed by a multidisciplinary referral to a paediatric cardiologist and metabolic specialist at a DHA-licensed facility.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Protection
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All patient data collected, processed, and stored in compliance with PDPL requirements for consent, purpose limitation, and data security.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: ICT systems and telephonic consultations adhere to the statutory standards for electronic health data handling and confidentiality.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical procedures, patient consent, and safety protocols follow the established medical liability framework.
Clinical & Logistical Metadata
| Test Name | ABCC6 Gene Sequencing โ Generalized Arterial Calcification Type 2 (Infantile) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | E83.59 |
| LOINC Code | 21615-9 (ABCC6 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
[]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians